Matches in Wikidata for { <http://www.wikidata.org/entity/Q92504921> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q92504921 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92504921 description "scientific article published on 14 May 2019" @default.
- Q92504921 description "wetenschappelijk artikel" @default.
- Q92504921 description "наукова стаття, опублікована 14 травня 2019" @default.
- Q92504921 name "Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies" @default.
- Q92504921 name "Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies" @default.
- Q92504921 type Item @default.
- Q92504921 label "Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies" @default.
- Q92504921 label "Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies" @default.
- Q92504921 prefLabel "Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies" @default.
- Q92504921 prefLabel "Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies" @default.
- Q92504921 P1433 Q92504921-2C330BA2-EA6A-4485-9B56-B63A5DCB0844 @default.
- Q92504921 P1476 Q92504921-9127F51D-D83B-4EB3-BCA8-4497F9D92187 @default.
- Q92504921 P2093 Q92504921-C0E336A6-8324-4A3D-973C-3198E5D6AA5A @default.
- Q92504921 P2860 Q92504921-3C252FE0-F630-415E-B97A-30A151E6F27A @default.
- Q92504921 P2860 Q92504921-60492ACC-8E5B-4E03-A105-242D2CE59190 @default.
- Q92504921 P2860 Q92504921-9452D4A0-663D-488D-B6D5-7276075F8267 @default.
- Q92504921 P304 Q92504921-253202BE-A643-4FD0-92CB-BCD89906C09B @default.
- Q92504921 P31 Q92504921-A0E2678A-D100-49DD-84A5-0B322E47ABA8 @default.
- Q92504921 P356 Q92504921-A50CBFF9-2829-4D9C-A540-417E146BC19B @default.
- Q92504921 P433 Q92504921-46DF65C4-3891-470F-AA18-3993913C1746 @default.
- Q92504921 P478 Q92504921-A8F21B3D-45C9-4AEE-856B-46ACAA21E487 @default.
- Q92504921 P50 Q92504921-BDF9CCBE-374F-46E6-BD5D-BE9A94C79B80 @default.
- Q92504921 P50 Q92504921-E12515C7-4327-48EE-A234-C57A2B59EE02 @default.
- Q92504921 P577 Q92504921-442C854E-DC1B-46A9-A12D-1149D3E6D320 @default.
- Q92504921 P698 Q92504921-57C9E331-B9E8-49A6-AC34-7153185C25BF @default.
- Q92504921 P356 EJI.201848042 @default.
- Q92504921 P698 30893471 @default.
- Q92504921 P1433 Q5412727 @default.
- Q92504921 P1476 "Rituximab/Bendamustine treatment of chronic lymphatic leukemia leads to sustained remission of antiphospholipid antibodies" @default.
- Q92504921 P2093 "Mira Merashli" @default.
- Q92504921 P2860 Q38061406 @default.
- Q92504921 P2860 Q56956569 @default.
- Q92504921 P2860 Q80675965 @default.
- Q92504921 P304 "969-970" @default.
- Q92504921 P31 Q13442814 @default.
- Q92504921 P356 "10.1002/EJI.201848042" @default.
- Q92504921 P433 "6" @default.
- Q92504921 P478 "49" @default.
- Q92504921 P50 Q56135280 @default.
- Q92504921 P50 Q92504918 @default.
- Q92504921 P577 "2019-05-14T00:00:00Z" @default.
- Q92504921 P698 "30893471" @default.